Trial Profile
Clinical Effects of Diquas-S for Patients With Dry Eye After Cataract Surgery
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Oct 2020
Price :
$35
*
At a glance
- Drugs Diquafosol (Primary)
- Indications Dry eyes; Meibomian gland dysfunction
- Focus Therapeutic Use
- 01 Oct 2020 Status changed from recruiting to completed.
- 07 Feb 2019 Planned End Date changed from 10 Jan 2019 to 14 Aug 2019.
- 07 Feb 2019 Planned primary completion date changed from 10 Jan 2019 to 14 Aug 2019.